International Journal of Nursing Studies
Volume 41, Issue 3 , Pages 321-330 , March 2004

The effectiveness of nicotine-patch therapy for smoking cessation in patients with schizophrenia

  • Kuei-Ru Chou

      Affiliations

    • National Defense Medical Center, School of Nursing, No. 161, Sec. 6 Min-Chuan East Road, Nei-Hu, Taipei 114, Taiwan, ROC
    • Corresponding Author InformationCorresponding author. Tel.: +886-2-87923100; fax: +886-2-87923109
    • ,
  • Ruey Chen

      Affiliations

    • Nursing Department, Tri-Service General Hospital, Taiwan, ROC
    • ,
  • Jia-Fu Lee

      Affiliations

    • Department of Psychiatry, Armed Forces Pei-Tou Hospital, Taiwan, ROC
    • ,
  • Chih-Hung Ku

      Affiliations

    • National Defense Medical Center, Taiwan, ROC
    • ,
  • Ru-Band Lu

      Affiliations

    • Psychiatric Department, Tri-Service General Hospital, Taiwan, ROC

Received 28 January 2003 ,Revised 30 June 2003 ,Accepted 14 July 2003.

References 

  1. Addington J, el-Guebaly N, Addington D, Hodgins D. Readiness to stop smoking in schizophrenia. Canadian Journal of Psychiatry—Revue Canadienne de Psychiatrie. 1997;42(1):49–52
  2. Attington J, el-Guebaly N, Campbell W, Hodgins DC, Addington D. Smoking cessation treatment for patients with schizophrenia. American Journal of Psychiatry. 1998;155(7):974–976
  3. Bohadana A, Nilsson F, Rasmussen T, Martinet Y. Nicotine inhaler and nicotine patch as a combination therapy for smoking cessation (a randomized, double-blind, placebo-controlled trial). Archives of Internal Medicine. 2000;160(20):3128–3134
  4. Centers for Disease Control, 1993. 1990 Smoking: attributable mortality and years of potential life lost—Unites Sates. MMWR, 42, p. 645.
  5. Centers for Disease Control and Prevention, 2000. 1998 Behavioral risk factor surveillance system summary prevalence report (online). Available at http://www.cdc.gov\nccdphp\brfss\ (revised).
  6. Chen R, Ku CH, Lu RB, Chou KR. The impact of smoking cessation programs on smoking-related health belief and rate of quit-smoking among schizophrenic patients. Journal of Medical Sciences. 2002;22(5):215–220
  7. Chou KR, Liu SY, Chu H. The effects of support groups on caregivers of patients with schizophrenia. International Journal of Nursing Studies. 2002;39:713–722
  8. Cohen J. Statistical Power Analysis for the Behavioral Sciences, 2nd Edition. Illsdale, NJ: Lawrence Erlbaum Associates; 1988;
  9. Cohen S, Lichtenstein E, Prochaska JO, Rossi JS, Gritz ER, Carr CR, et al. Debunking myths about self-quitting (evidence from 10 prospective studies of persons who attempt to quit smoking by themselves). American Psychologist. 1989;44(11):1355–1365
  10. Dalack GW, Meador-Woodruff JH. Acute feasibility and safety of a smoking reduction strategy for smokers with schizophrenia. Nicotine and Tobacco Research. 1999;1:53–57
  11. Dale LC, Ebbert JO, Hays JT, Hurt RD. Treatment of nicotine dependence. Mayo Clinical Protocol. 2000;75(12):1311–1316
  12. Davidson M, Epstein M, Burt R, Schaefer C, Whitworth G, McDonald A. Efficacy and safety of an over-the-counter transdermal nicotine patch as an aid for smoking cessation. Archives of Family Medicine. 1998;7(6):569–574
  13. Fagerstrom KO, Schneider NG. Measuring nicotine dependence (a review of the Fagerstrom tolerance questionnaire). Journal of Behavioral Medicine. 1989;12(2):159–182
  14. Farnam CR. Zyban (a new aid to smoking cessation treatment—will it work for psychiatric patients). Journal of Psychosocial Nursing. 1999;37(2):36–43
  15. Fiore MC, Smith SS, Jorenby DE, Baker TB. The effectiveness of the nicotine patch for smoking cessation (a meta-analysis). JAMA: The Journal of the American Medical Association. 1994;271(24):1940–1947
  16. Gjerris A, Bech P, Bojholm S, Bolwig TG, Kramp P, Clemmesen L, et al. The hamilton anxiety scale (evaluation of homogeneity and inter-observer reliability in patients with depressive disorders). Journal of Affective Disorders. 1983;5(2):163–170
  17. Hartman N, Leong GG, Glynn SM, Wilkins JN, Jarvik ME. Transdermal nicotine and smoking behavior in psychiatric patients. American Journal of Psychiatry. 1991;148:374–375
  18. Hays JT, Croghan IT, Schroeder DR, Offord KP, Hurt RD, Wolter T, et al. Over-the-counter nicotine patch therapy for smoking cessation (results from randomized, double-blind, placebo-controlled, and open label trials). American Journal of Public Health. 1999;89(11):1701–1707
  19. Herdman, R., Hewitt, M., Laschober, M., 1993. Smoking-related deaths and financial costs: Office of Technology Assessment estimates for 1990. Congress of the United States, Office of Technology Assessment.
  20. Hughes JR, Hatsukami DK, Mitchell JE, Dahlgren LA. Prevalence of smoking among psychiatric outpatients. American Journal of Psychiatry. 1986;143(8):993–997
  21. Hurt RD, Dale LC, Fredrickson PA, Caldwell CC, Lee GA, Offord KP, et al. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up (one-year outcome and percentage of nicotine replacement). JAMA: the Journal of the American Medical Association. 1994;271(8):595–600
  22. Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Hughes AR, et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. The New England Journal of Medicine. 1999;340(9):685–691
  23. Joseph AM, Norman SM, Ferry LH, Prochazka AV, Westman EC, Steele BG, et al. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. The New England Journal of Medicine. 1996;335(24):1792–1798
  24. Lohr JB, Flynn K. Smoking and schizophrenia. Schizophrenia Research. 1992;8(2):93–102
  25. Masterson E, O’Shea B. Smoking and malignancy in schizophrenia. British Journal of Psychiatry. 1984;145:429–432
  26. Menza MA, Grossman N, Van Horn M, Cody R, Forman N. Smoking and movement disorders in psychiatric patients. Biological Psychiatry. 1991;30(2):109–115
  27. Morlan KK, Tan SY. Comparison of Brief Psychiatric Rating Scale and the Brief Symptom Inventory. Journal of Clinical Psychology. 1998;54(7):885–894
  28. Murray RP, Connett JE, Lauger GG, Voelker HT. Error in smoking measures (effects of intervention on relations of cotinine and carbon monoxide to self-reported smoking). American Journal of Public Health. 1993;83(9):1251–1257
  29. O’Farrell TJ, Connors GJ, Upper D. Addictive behaviors among hospitalized schizophrenic patients. Addictive Behaviors. 1983;8(4):329–333
  30. Radzius A, Moolchan ET, Henningfield JE, Heishman SJ, Gallo JJ. A factor analysis of the Fagerstrom tolerance questionnaire. Addictive Behavior. 2001;26(2):303–310
  31. Resnick MP, Bosworth EE. A smoke-free psychiatric unit. Hospital Community Psychiatry. 1989;40(5):525–527
  32. Sachs DP, Sawe U, Leischow SJ. Effectiveness of a 16-hour transdermal nicotine patch in a medical practice setting, without intensive group counseling. Archives of Internal Medicine. 1993;153(16):1881–1890
  33. Silagy, C., Mant, D., Fowler, G., Lodge, M., 1994. The effectiveness of nicotine replacement therapies in smoking cessation. Online Journal of Current Clinical Trials, Doc No. 113.
  34. Thorsteinn B, Jon GL, Ingileif O, Gunnar G, Ake W. Nicotine nasal spray with nicotine patch for smoking cessation (randomized trial with six year follow-up). British Medical Journal. 1999;318(7179):285–288
  35. Thorward SR, Birnbaum S. Effects of a smoking ban on a general hospital psychiatric unit. General Hospital Psychiatry. 1989;11(1):63–67
  36. Tidey JW, O’Neill SC, Higgins ST. Contingent monetary reinforcement of smoking reductions, with and without transdermal nicotine, in outpatients with schizophrenia. Experimental and Clinical Psychopharmacology. 2002;10(3):241–247
  37. Van Dongen CJ. Smoking and persistent mental illness (an exploratory study). Journal of Psychosocial Nursing. 1999;37(11):26–34
  38. Van Dongen CJ, Kriz P, Fox KA, Haque I. A quit smoking group (pilot study). Journal of Psychosocial Nursing. 1999;37(12):31–36
  39. Wagner B, Wolf GK, Ulmar K. Does smoking reduce the risk of neuroleptic Parkinsonoids?. Pharmacopsychiatry. 1988;21(6):302–303
  40. Westman EC, Levin ED, Rose JE. The nicotine patch in smoking cessation (a randomized trial with telephone counseling). Archives of Internal Medicine. 1993;153(16):1917–1923
  41. Ziedonis DM, George TP. Schizophrenia and nicotine use (report of a pilot smoking cessation program and review of Neurobiological and clinical issues). Schizophrenia Bulletin. 1997;23(2):247–254

PII: S0020-7489(03)00168-8

doi: 10.1016/j.ijnurstu.2003.07.001

International Journal of Nursing Studies
Volume 41, Issue 3 , Pages 321-330 , March 2004

Article Tools

* Image Usage & Resolution